NorthView Acquisition Corporation Warrant
Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. The company offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. It also researches and develops the Lumee Glucose Platform which is designed to monitor … Read more
NorthView Acquisition Corporation Warrant (NVACW) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.007x
Based on the latest financial reports, NorthView Acquisition Corporation Warrant (NVACW) has a cash flow conversion efficiency ratio of 0.007x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-139.17K) by net assets ($-21.18 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
NorthView Acquisition Corporation Warrant - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how NorthView Acquisition Corporation Warrant's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
NorthView Acquisition Corporation Warrant Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NorthView Acquisition Corporation Warrant ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Johan Holdings Bhd
KLSE:3441
|
-0.013x |
|
INCREDIBLE INDUSTRIES LIMITED
NSE:INCREDIBLE
|
0.019x |
|
CPL Group Public Company Limited
BK:CPL
|
0.066x |
|
Nutra Pharma Corp
PINK:NPHC
|
-0.001x |
|
ELMOS SEMICONDUCTOR - Dusseldorf Stock Exchang
DU:ELG
|
0.046x |
|
HYDRIX Ltd
AU:HYD
|
0.212x |
|
Gathid Ltd
AU:GTH
|
-0.431x |
|
D2 Lithium Corp.
OTCQB:DTWOF
|
0.006x |
Annual Cash Flow Conversion Efficiency for NorthView Acquisition Corporation Warrant (2021–2024)
The table below shows the annual cash flow conversion efficiency of NorthView Acquisition Corporation Warrant from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-4.62 Million | $-1.30 Million | 0.281x | +178.76% |
| 2023-12-31 | $5.79 Million | $-2.06 Million | -0.356x | -11731.04% |
| 2022-12-31 | $192.91 Million | $-581.19K | -0.003x | +15.52% |
| 2021-12-31 | $185.74 Million | $-662.39K | -0.004x | -- |